The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

19 Oct 2021 17:48

RNS Number : 5853P
Man Group plc
19 October 2021
 

 

Transactions in own shares

 

Man Group plc (the "Company") announces that it has purchased the following number of its ordinary shares of 3 3/7 US cents on the London Stock Exchange through Credit Suisse International as part of its US$100 million share buyback programme announced on 10 August 2021.

 

Date of purchase: 19/10/2021

 

Number of ordinary shares purchased: 880,248

 

Time of transaction: 08:00 to 16:35

 

Highest price per share 231.2000

Lowest price per share 226.8000

 

Weighted average price per share 228.9284

 

The Company intends to hold the purchased shares in treasury. Following the purchase and settlement of these shares, the Company will hold 134,703,479 of its ordinary shares in treasury and will have 1,407,091,291 ordinary shares in issue (excluding treasury shares).

 

Since the commencement of the share repurchase programme, the Company has repurchased 25,920,067 ordinary shares in aggregate at a weighted average price of 212.6163 pence per share.

 

All transactions under this programme will be published on the Company's website (www.man.com) on a weekly basis.

 

Enquiries

Karan Shirgaokar

Director, Investor Relations

+44 (0)20 7144 1434

investor.relations@man.com

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPGMCUUPGGQB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.